Downregulation of SNCA Expression as a Therapoetic Approach for Parkinson's Disease and Other Synucleinopathies: New Target Validation for Next-Generation Drug Discovery

Conference Paper

Full Text

Link to Item

Duke Authors

Cited Authors

Kantor, B; Dong, W; Rittiner, J; Poe, J; Chiba-Falek, O

Published Date

April 27, 2021

Published In

Molecular Therapy

Volume / Issue

29 / 4

Start / End Page

265 - 266

Electronic International Standard Serial Number (EISSN)

1525-0024

International Standard Serial Number (ISSN)

1525-0016